A decrease in mitochondrial transcription factor A (TFAM) and peroxisome proliferator-activated receptor coactivator-1 alpha (PGC1α) were found in imatinib-sensitive GIST cells upon imatinib treatment (Figure 2a,b). The gene discussed is TFAM; the disease is gastrointestinal stromal tumor.